Life on hold – How Canada’s drug approval delays endanger patients: Nigel S.B. Rawson and John Adams
By Nigel S.B. Rawson and John AdamsMarch 13, 2025 Introduction Health care across Canada is in crisis. In…
Rawson
One federal agency we could axe? The drug prices review board: Nigel Rawson and John Adams in the Financial Post
This article originally appeared in the Financial Post. By Nigel Rawson and John Adams, February 5, 2025 The…
Canada’s national pharmacare plan – boon or bane?: Nigel Rawson and John Adams
By Nigel Rawson and John AdamsJanuary 24, 2025 PDF of commentary Introduction National pharmacare, as proposed by the…
No rare disorder sufferer should be left behind – The troubling case of spinal muscular atrophy: Nigel Rawson and John Adams in National Newswatch
This article originally appeared in National Newswatch. By Nigel Rawson and John Adams, October 30, 2024 Many can…